Gross RH, Corboy JR. Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies. Continuum (Minneap Minn). 2019 Jun;25(3):715-735. PubMed PMID: 31162313
Piquet AL, Alvarez E (Eds.) “Use of Disease-Modifying Therapies in Multiple Sclerosis.” John Corboy and Robert Gross. Neuroimmunology: Multiple Sclerosis, Autoimmune Neurology, and Related Diseases. Springer: 2021, pp 493-506.
Barrera, B., Simpson, H., Engebretson, E., Sillau, S., Valdez, B., Parra-González, J., Winger, R.C., Epperson, L.A., Banks, A., Pierce, K., Spotts, M., O'Gean, K., Alvarez, E., Gross, R., Piquet, A.L., Schreiner, T., Corboy, J.R., Pei, J., Vollmer, T.L. and Nair, K.V. Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosis. Ann Clin Transl Neurol 2023 Apr; 10(4):579-588. https://doi.org/10.1002/acn3.51745
Spain RI, Hildebrand A, Waslo CS, Rooney WD, Emmons J, Schwartz DL, Freedman MS, Mateo Paz Soldan M, Repovic P, Solomon AJ, Rinker J, Wallin M, Haselkorn J, Stuve O, Gross RH, Turner AP. Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis. Front Neurol 2023 Jun; 14:1188124
https://doi.org/10.3389/fneur.2023.1188124
Borko TL, Baxter R, Cabrera-Martinez B, Thiruppathi E, Sabalza M, Venkataraman I, Selva S, Rester C, Sillau S, Pastula DM, Bennett JL, Alvarez E, Gross R, Shah A,
Kammeyer R, Corboy JR, Kedl RM, Hsieh EWY, Piquet AL. SARS-CoV-2 mRNA Vaccination Induces an Antigen-Specific T Cell Response Correlating with Plasma Interferon-gamma in B Cell Depleted Patients. J Neuroimmunol 2023 Oct. 383:578192.
doi: 10.1016/j.jneuroim.2023.578192
Gross R, Selva S, Ritchie A, Sillau S. Using Plasma NfL and GFAP to Monitor Response to Anti-CD20 Treatment in MS. Poster presentation at American Academy of Neurology Annual Meeting; Apr 22- 27, 2023; Boston, MA.
Borko TL, Barrera B, Ritchie A, Selva S, Sillau S, Engebretson E, Seale R, Valdez B, Alvarez E, Corboy J, Shah A, Gross R, Silva D, Owens G, Piquet AL, Bennett JL, Vollmer TL, Chahin S, Nair KV. Establishing Demographic and Comorbidity based Reference Ranges for NfL and GFAP in Healthy Controls. Poster presentation at American Academy of Neurology Annual Meeting; Apr 22- 27, 2023; Boston, MA.
Borko TL, Barrera B, Ritchie A, Selva S, Sillau S, Engebretson E, Seale R, Valdez B, Alvarez E, Corboy J, Shah A, Gross R, Silva D, Owens G, Piquet AL, Bennett JL, Vollmer TL, Chahin S, Nair KV. Establishing Baseline Demographic Specific Reference Ranges for NfL and GFAP in Healthy Controls. Poster presentation at ACTRIMS Forum February 23-25, 2023; San Diego, CA.
Clinical Interests
Multiple Sclerosis and related disorders of the nervous system
Care Philosophy
I believe in using the most up-to-date clinical evidence and a collaborative multidisciplinary approach to provide patients with optimal care.